首页|止痛化癥胶囊联合阿莫西林克拉维酸钾片治疗慢性盆腔炎患者的效果

止痛化癥胶囊联合阿莫西林克拉维酸钾片治疗慢性盆腔炎患者的效果

扫码查看
目的:观察止痛化癥胶囊联合阿莫西林克拉维酸钾片治疗慢性盆腔炎患者的效果.方法:回顾性分析2020年10月至2023年10月该院收治的68例慢性盆腔炎患者的临床资料,按照治疗方法不同将其分为研究组与对照组各34例.对照组予以阿莫西林克拉维酸钾片治疗,研究组在对照组基础上联合止痛化癥胶囊治疗,两组均连续治疗14 d.比较两组临床疗效,治疗前后中医证候积分、炎性因子[C反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)]水平,以及不良反应发生率.结果:研究组治疗总有效率为88.24%(30/34),高于对照组的67.65%(23/34),差异有统计学意义(P<0.05);治疗后,研究组带下量多、发热头痛、下腹胀痛或刺痛等中医证候积分均低于对照组,差异有统计学意义(P<0.05);治疗后,研究组CRP、IL-6、TNF-α水平均低于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:止痛化癥胶囊联合阿莫西林克拉维酸钾片治疗慢性盆腔炎患者可提高治疗总有效率,降低中医证候积分和炎性因子水平,效果优于单纯阿莫西林克拉维酸钾片治疗.
Effects of Zhitong Huazheng capsules combined with Amoxicillin and Clavulanate potassium tablets in treatment of patients with chronic pelvic inflammatory disease
Objective:To observe effects of Zhitong Huazheng capsules combined with Amoxicillin and Clavulanate potassium tablets in treatment of patients with chronic pelvic inflammatory disease. Methods:The clinical data of 68 patients with chronic pelvic inflammatory disease admitted to this hospital from October 2020 to October 2023 were retrospectively analyzed. According to different treatment methods,they were divided into study group and control group,34 cases in each group. The control group was treated with Amoxicillin and Clavulanate potassium tablets,while the study group was treated with Zhitong Huazheng capsules on the basis of that of the control group. Both groups were treated for 14 d. The clinical efficacy,the TCM syndrome scores and the inflammatory factors[C-reactive protein (CRP),tumor necrosis factor-α (TNF-α),interleukin-6 (IL-6)]levels before and after the treatment,and the incidence of adverse reactions were compared between the two groups. Results:The total effective rate of the study group was 88.24% (30/34),which was higher than 67.65% (23/34) of the control group,and the difference was statistically significant (P<0.05). After the treatment,the scores of TCM syndromes such as large amount of leucorrhea,fever and headache,lower abdominal distension or tingling in the study group were lower than those in the control group,and the differences were statistically significant (P<0.05). After the treatment,the levels of CRP,IL-6 and TNF-α in the study group were lower than those in the control group,and the differences were statistically significant (P<0.05). However,there was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusions:Zhitong Huazheng capsules combined with Amoxicillin and Clavulanate potassium tablets in the treatment of the patients with chronic pelvic inflammatory disease can improve the total effective rate of treatment and reduce the TCM syndrome scores and the inflammatory factor levels. Moreover,it is superior to simple Amoxicillin and Clavulanate potassium tablets treatment.

Zhitong Huazheng capsulesAmoxicillin and Clavulanate potassium tabletsChronic pelvic inflammatory diseaseTCM syndrome scoreInflammatory factorAdverse reaction

陈建玲、杨静

展开 >

高安市大城中心卫生院妇产科,江西 宜春 330814

止痛化癥胶囊 阿莫西林克拉维酸钾片 慢性盆腔炎 中医证候积分 炎性因子 不良反应

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(23)